Cell and Gene Therapy Strategic Roundup | Sep 1 – Oct 6, 2026
Gene and cell therapy competition is shifting beyond efficacy. Durability,…
Lundbeck Expands EVERSANA AI Commercialization | Lucid Diligence Brief
Lundbeck Expands EVERSANA AI Across Its U.S. Commercial Organization…
Conavi Medical Raises C$10 Million in Public Offering | Lucid Diligence Brief
Conavi Medical’s C$10M Financing Puts Novasight U.S. Adoption and Funding…
Innovent-Lilly Verzenios China Commercialization | Lucid Diligence Brief
Innovent takes mainland China commercial responsibility for Verzenios as Lilly…
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in localized prostate cancer
Lucid Diligence Brief: Candel Therapeutics $100m funding for CAN-2409 in…
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled rare-disease therapeutics
Lucid Diligence Brief: Mendra $82 million Series A to support AI-enabled…
Lucid Diligence Brief: Impulse Dynamics $158m financing
Lucid Diligence Brief: Impulse Dynamics $158m financing Professional audiences…